Timber Pharmaceuticals Inc Extraordinary Shareholders Meeting Transcript
Good afternoon. I'm John Koconis, Chief Executive Officer and Chairman of the Board of Directors of Timber Pharmaceuticals, Inc. I'd like to welcome each of you to the special meeting of stockholders being held by remote communication.
Before I begin the formal portion of this meeting, I would like to take this opportunity to introduce Gregory Malatia, who will act as the Independent Inspector of Elections. Representatives of Lowenstein Sandler LLP, our outside Corporate Counsel, are also present.
Prior to the meeting, I appointed Joseph Lucchese as acting secretary of the meeting. I asked Mr. Lucchese to include with the minutes of the meeting a copy of the affidavit of distribution, a certified list of stockholders, a notice of meeting, and the proxy statement which we refer to as the proxy materials. The notice of meeting and proxy statement were filed with the Securities and Exchange Commission on October 17, 2022. The proxy statement describes the record date for this meeting and the number of eligible votes of common
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |